Impact of patient sex and dual antiplatelet therapy duration on 10-year mortality following percutaneous coronary intervention with drug-eluting stents: A post-hoc analysis of the ISAR-SAFE trial
Impact of patient sex and dual antiplatelet therapy duration on 10-year mortality following percutaneous coronary intervention with drug-eluting stents: A post-hoc analysis of the ISAR-SAFE trial. // Cardiovascular Revascularization Medicine. – URL: https://www.sciencedirect.com/science/article/pii/S1553838926004756?dgcid=rss_sd_all
Impact of patient sex and dual antiplatelet therapy duration on 10-year mortality following percutaneous coronary intervention with drug-eluting stents: A post-hoc analysis of the ISAR-SAFE trial. Cardiovascular Revascularization Medicine. https://www.sciencedirect.com/science/article/pii/S1553838926004756?dgcid=rss_sd_all
“Impact of patient sex and dual antiplatelet therapy duration on 10-year mortality following percutaneous coronary intervention with drug-eluting stents: A post-hoc analysis of the ISAR-SAFE trial.” Cardiovascular Revascularization Medicine.
@article{article39755,
title = {Impact of patient sex and dual antiplatelet therapy duration on 10-year mortality following percutaneous coronary intervention with drug-eluting stents: A post-hoc analysis of the ISAR-SAFE trial},
journal = {Cardiovascular Revascularization Medicine},
url = {https://www.sciencedirect.com/science/article/pii/S1553838926004756?dgcid=rss_sd_all}
}